loader
Please Wait
Applying Filters...

Seqens Seqens

X

Approved Drug Products containing 211765 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 ABBVIE (2)

filter

01 TABLET;ORAL (2)

filter

01 RX (2)

filter

01 UBRELVY (2)

filter

01 Yes (2)

URL Supplier Web Content
TABLET; ORAL
100MG
2019-12-23
211765
UBRELVY
RX
Yes
Abbvie Company Banner

Cophex 2024

Not Confirmed

envelop Contact Supplier
URL Supplier Web Content
TABLET; ORAL
50MG
2019-12-23
211765
UBRELVY
RX
Yes
Abbvie Company Banner

Cophex 2024

Not Confirmed

envelop Contact Supplier

Looking for FDA Orange Book APPLICATION 211765

Looking for FDA Orange Book APPLICATION 211765 2

19

AbbVie Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is UBROGEPANT, with a corresponding application number 211765.

Regulatory Information RX

With a dosage strength 100MG

Dosage Form Route TABLET; ORAL

Reference Listed Drug Yes

Approved since 2019-12-23

18

AbbVie Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is UBROGEPANT, with a corresponding application number 211765.

Regulatory Information RX

With a dosage strength 50MG

Dosage Form Route TABLET; ORAL

Reference Listed Drug Yes

Approved since 2019-12-23

Post Enquiry
POST ENQUIRY